299 results on '"Bush, Errol L."'
Search Results
2. Age and associated outcomes among patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory failure: analysis of the Extracorporeal Life Support Organization registry
3. Use of Extracorporeal Membrane Oxygenation for Patients with Coronavirus Disease 2019 Infection
4. Acute brain injury risk prediction models in venoarterial extracorporeal membrane oxygenation patients with tree-based machine learning: An Extracorporeal Life Support Organization Registry analysis
5. Impact of Extracorporeal Membrane Oxygenation Bridging Duration on Lung Transplant Outcomes
6. National utilization, trends, and lung transplant outcomes of static versus portable ex vivo lung perfusion platforms
7. Extracorporeal Membrane Oxygenation Physiological Factors Influence Pulse Oximetry and Arterial Oxygen Saturation Discrepancies
8. To decline or not to decline: Consequences of decision-making regarding lung offers from donors with hepatitis C
9. Lower Oxygen Tension and Intracranial Hemorrhage in Veno-venous Extracorporeal Membrane Oxygenation
10. Debunking the July Effect in lung transplantation recipients
11. Impact of recipient age on mortality among Cytomegalovirus (CMV)-seronegative lung transplant recipients with CMV-seropositive donors
12. Outcomes of Lung Transplant Candidates Aged ≥70 Years During the Lung Allocation Score Era
13. Racial Disparities in Waiting List Outcomes of Patients Listed for Lung Transplantation
14. Racial disparities among patients on venovenous extracorporeal membrane oxygenation in the pre–Coronavirus Disease 2019 and Coronavirus Disease 2019 eras: A retrospective registry review
15. Uptake and 1-year outcomes of lung transplantation for COVID-19
16. The effect of allograft ischemic time on outcomes following bilateral, single, and reoperative lung transplantation
17. Outcomes of Recipients Aged 65 Years and Older Bridged to Lung Transplant With Extracorporeal Membrane Oxygenation
18. Outcomes of single vs double lung retransplantation in patients with cystic fibrosis
19. Lung Transplantation Outcomes and Peritransplant Sirolimus Use in Lymphangioleiomyomatosis
20. Impact of dual thoracic recovery from circulatory death donors on heart and lung transplant outcomes
21. For your consideration: Benefits of listing as willing to consider heart offers from donors with hepatitis C
22. Using machine learning to predict neurologic injury in venovenous extracorporeal membrane oxygenation recipients: An ELSO Registry analysis
23. Bigger pies, bigger slices: Increased hospitalization costs for lung transplantation recipients in the non–donation service area allocation era
24. Extracorporeal membrane oxygenation as a bridge to lung transplantation: Practice patterns and patient outcomes
25. National Trends, Risk Factors, and Outcomes of Acute In-Hospital Stroke Following Lung Transplantation in the United States: Analysis of the United Network for Organ Sharing Registry
26. Early United States experience with lung donation after circulatory death using thoracoabdominal normothermic regional perfusion
27. Neuromonitoring detects brain injury in patients receiving extracorporeal membrane oxygenation support
28. Trends in use and three-year outcomes of hepatitis C virus–viremic donor lung transplants for hepatitis C virus–seronegative recipients
29. Lung Transplantation in Patients With COVID-19-The Early National Experience
30. Trends and three-year outcomes of hepatitis C virus–viremic donor heart transplant for hepatitis C virus–seronegative recipients
31. Assessing the SAfety and FEasibility of bedside portable low-field brain Magnetic Resonance Imaging in patients on ECMO (SAFE-MRI ECMO study): study protocol and first case series experience
32. Neurological Complications in COVID-19 Patients With ECMO Support: A Systematic Review and Meta-Analysis
33. Consensus Statement: Technical Standards for Thoracoabdominal Normothermic Regional Perfusion.
34. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
35. Nutritional Risk Index: A Predictive Metric for Mortality After Lung Transplant
36. Acute Brain Injury in Postcardiotomy Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation
37. What Is the Current Status of Lung Transplantation?
38. Cell-Free DNA Maps Tissue Injury and Correlates with Disease Severity in Lung Transplant Candidates
39. National utilization, trends, and lung transplant outcomes of static vs. portable ex vivo lung perfusion platforms
40. Outcomes of Recipients Aged 65 Years and Older Bridged to Lung Transplant With Extracorporeal Membrane Oxygenation
41. Surgical Perspective on the American Thoracic Society Statement on Race Correction of Pulmonary Function Testing
42. Epigenetic therapy inhibits metastases by disrupting premetastatic niches
43. Unconscious Bias: Addressing the Hidden Impact on Surgical Education
44. Better Understanding the Disparity Associated With Black Race in Heart Transplant Outcomes: A National Registry Analysis
45. Cell-Free DNA Maps Tissue Injury and Correlates with Disease Severity in Lung Transplant Candidates.
46. Trends in Heart and Lung Transplantation in the United States Across the COVID-19 Pandemic
47. Extracorporeal Membrane Oxygenation Physiological Factors Influence Pulse Oximetry and Arterial Oxygen Saturation Discrepancies
48. To decline or not to decline: Consequences of decision-making regarding lung offers from donors with hepatitis C
49. Risk Factors of Ischemic and Hemorrhagic Strokes During Venovenous Extracorporeal Membrane Oxygenation: Analysis of Data From the Extracorporeal Life Support Organization Registry
50. Uptake and 1-year outcomes of lung transplantation for COVID-19
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.